title: Hypertrophic osteopathy in rats following chronic administration of SDZ MNS 949, an isoquinoline.
abstract: SDZ MNS 949, 6,7-dimethoxy-3-methyl-1-(3',5'-bis (methoxyethoxy) phenyl)-isoquinoline, a bronchodilating anti-inflammatory drug that inhibits phosphodiesterase, had been proposed for the treatment of bronchial asthma. Groups of 14 male and 14 female Wistar rats were administered doses of 12, 50, and 130 mg/kg/day in feed for 26 weeks. Periodic radiographic examinations were performed in addition to clinical observations, clinical chemistry measurements and urinalysis. At study termination full necropsy and histopathological examinations were performed on all animals. The principal clinical signs observed were unilateral edematous, red and painful swelling of the distal hindlimbs in 8 of 28 high dose animals, and abdominal swelling in 19 of 28 high dose animals. At radiographic examination periosteal new bone formation was predominantly along the tibia. Lesions at necropsy included dilated small and large intestines. Microscopically, enteritis was observed, and the periosteal new bone formation was confirmed. Hematological findings consisted of thrombocytosis and lymphocytosis, especially in high dose animals. The clinical, radiographical and histological findings in treated rats were consistent with the diagnosis of "hypertrophic osteopathy" or "Marie's Disease".
authors.affiliation: Sandoz Pharma Ltd., Basle, Switzerland.
authors.forename: U W
authors.initials: UW
authors.lastname: Längle
authors.forename: S
authors.initials: S
authors.lastname: Brüggemann
authors.forename: D E
authors.initials: DE
authors.lastname: Prentice
authors.forename: R A
authors.initials: RA
authors.lastname: Ettlin
authors.forename: B
authors.initials: B
authors.lastname: Richardson
authors.forename: R
authors.initials: R
authors.lastname: Naef
authors.forename: A
authors.initials: A
authors.lastname: Cordier
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000633:toxicity*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000633:toxicity*; D005260:Female; D007546:Isoquinolines / Q000008:administration & dosage / Q000633:toxicity*; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D010005:Osteoarthropathy, Secondary Hypertrophic / Q000097:blood / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D010976:Platelet Count / Q000187:drug effects; D011859:Radiography; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001993:Bronchodilator Agents; D007546:Isoquinolines; C088777:SDZ MNS 949